Futurepharma Strengthens South Africa’s Capacity to Develop and Manufacture Essential Medicines
The launch of the Council for Scientific and Industrial Research’s (CSIR) FuturePHARMA facility in Pretoria strengthens South Africa’s capacity to develop and manufacture essential pharmaceutical products locally, helping address the vulnerability exposed by dependence on international supply chains during the COVID-19 pandemic. The Chairperson of the Portfolio Committee on Science, Technology and Innovation, Ms Lusizo Makhubela, attended the official launch today and said facilities such as FuturePHARMA demonstrate why sustained investment in science, technology and innovation matters. The Chairperson of the Portfolio Committee on Science, Technology and Innovation, Ms Lusizo Makhubela, attended the official launch of the Council for Scientific and Industrial Research’s (CSIR) FuturePHARMA facility in Pretoria today. The FuturePHARMA facility represents an important investment in South Africa’s science, technology and innovation (ST&I) capability and in the country’s capacity to translate scientific research into pharmaceutical products and local manufacturing. It provides specialised infrastructure and expertise to support the development, scale-up and manufacture of active pharm
Cancele cuando quiera · 99 CA$/mes
